CD274 and neoplasm: A comparison of the Ventana SP142, Ventana SP263, and Dako 22C3 IHC-validated assays showed the percentage of PD-L1-positive cells was consistently higher among immune cells than tumor cells across all three tests, but assay concordance was lower for immune cell vs. tumoral expression measurement [25].